Búsqueda - Portal Conocimiento Público CL

Artículo 2021

Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study

Autor: Parra Soto, Solange Ferreccio Readi, Catterine Cowley, Emma S. Rezende, Leandro F. M. Mathers, John C. Pell, Jill P. Ho, Frederick K. Celis Morales, Carlos

Abstract Background Adiposity is a strong risk factor for cancer incidence and mortality. However, most of the evidence available has focused on body mass index (BMI) as a marker of adiposity. There is limited evidence on relationships of cancer with...

Enlace original: https://repositorio.uc.cl/handle/11534/51207

Repositorio Pontificia Universidad Católica de Chile

Obesity

Body mass index

Waist circumference

Listar archivos Citar Enlace permanente

Parra Soto, Solange , Ferreccio Readi, Catterine , Cowley, Emma S. , Rezende, Leandro F. M. , Mathers, John C. , Pell, Jill P. , Ho, Frederick K. , Celis Morales, Carlos , [Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study] , Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study

Artículo 2018

Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.

Autor: Rolle, Augusto. Paredes, S. Cortínez Fernández, Luis Ignacio. Quezada, Nicolás. Solari Gajardo, Sandra. Allende, Fidel. Torres Fuentes, Jorge Luis Alejandro. Cabrera García, Daniel Alejandro. Contreras Ibacache, Víctor. Carmona, J.

Background: Obesity has been associated with reduced dexmedetomidine clearance, suggesting impaired hepatic function or reduced hepatic blood flow. The aim of this study was to clarify the effect of obesity in dexmedetomidine metabolic clearance. Methods: Forty patients, ASA IeIII, 18e60 yr old, ...

Enlace original: https://repositorio.uc.cl/handle/11534/29394

Repositorio Pontificia Universidad Católica de Chile

Anaesthetics i.v.

Dexmedetomidine

Obesity

Listar archivos Citar Enlace permanente

Rolle, Augusto. , Paredes, S. , Cortínez Fernández, Luis Ignacio. , Quezada, Nicolás. , Solari Gajardo, Sandra. , Allende, Fidel. , Torres Fuentes, Jorge Luis Alejandro. , Cabrera García, Daniel Alejandro. , Contreras Ibacache, Víctor. , Carmona, J. , [Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.] , Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.

Descubre y comparte nuestro conocimiento público

Resultados de búsqueda

Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study

Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.

Descubre y comparte nuestro conocimiento público

Resultados de búsqueda

Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study

[12916_2020_Article_1848.pdf]

Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.

[A.RolleBJA-Dexmedetomidine.pdf]